Safety liver profile of teriflunomide versus interferon ? in multiple sclerosis: Systematic review and indirect comparison meta-analysis

Objectives: To compare the liver safety profile of interferon ? (IFN ?) and teriflunomide in patients with multiple sclerosis. Methods: A network meta-analysis was carried out following the Cochrane Collaboration methodology. All trials comparing all types of IFN ? with teriflunomide, or disease-mod...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2018

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/22632

Acceso en línea:

https://doi.org/10.1016/j.msard.2018.09.014
https://repository.urosario.edu.co/handle/10336/22632

Palabra clave:

Alemtuzumab
Beta interferon
Daclizumab
Fingolimod
Glatiramer
Placebo
Teriflunomide
Beta interferon
Crotonic acid derivative
Immunologic factor
Teriflunomide
Toluidine derivative
Article
Drug efficacy
Drug safety
Human
Hypertransaminasemia
Liver function
Liver function test
Meta analysis
Multiple sclerosis
Systematic review
Toxic hepatitis
Treatment outcome
Comparative study
Drug effect
Liver
Multiple sclerosis
Toxic hepatitis
Chemical and drug induced liver injury
Crotonates
Humans
Immunologic factors
Interferon-beta
Liver
Multiple sclerosis
Toluidines
Interferon ?
Liver safety profile
Multiple sclerosis
Teriflunomide

Rights

License

Abierto (Texto Completo)